| 标题 |
 Efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with active psoriatic arthritis: 52-week results from the randomised, double-blind, placebo-controlled phase 3 POETYK PsA-1 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊：Annals of the Rheumatic Diseases 作者：Désirée van der Heijde; Philip J. Mease; Carle Paul; Frank Behrens; Laure Gossec; et al 出版日期：2026 |
| 求助人 | |
| 下载 | 求助已完成，仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
cdercder
Kao
v0id
大力的冬萱
lobster
NN
卡乐瑞咩吹可
嘉心糖
殷勤的紫槐
arniu2008
yjh123
完美巧凡
XLL小绿绿
aaaa
GingerF
OK
狄仁杰克
愉快的真
didiwang
ale
皖公网安备34019202002308
